Almac’s diagnostics business unit has received a Clinical Laboratory Permit from the New York State Department of Health, allowing them to receive patient samples for clinical testing from New York. Almac has also retained its CAP and CLIA lab accreditation following an inspection by the College of American Pathologists (CAP).  
 
“The growing importance of biomarkers in personalized medicine means that our clinical testing laboratories need to meet the highest standards of quality and safety” said Richard Kennedy, Clinical Laboratory director at Almac. “The successful receipt of the Clinical Laboratory Evaluation Program (CLEP) permit together with the recent renewal of our CAP accreditation demonstrates that we meet these standards and provides confidence to our clients.”